Fri Nov 22, 2024 5:38 pm
2024-Ferrario et al-Clin Cancer Res
"Phase Ib pharmacodynamic study of the MNK inhibitor Tomivosertib (eFT508) combined with paclitaxel in patients with refractory metastatic breast cancer"
Cristiano Ferrario, John Mackey, Karen A Gelmon, Nathalie Levasseur, Poul H Sorensen, Htoo Z Oo, Gian L Negri, Veronica W L Tse, Sandra E Spencer, Grace Cheng, Gregg B Morin, Sonia Del Rincon, Tiziana Cotechini, Christophe Gonçalves, Charles C T Hindmarch, Wilson H Miller, Mehdi Amiri, Tayebeh Basiri, Victor Villareal-Corpuz, Sam Sperry, Kevin Gregorczyk, Gonzalo Spera, Nahum Sonenberg, Michael Pollak
Clin Cancer Res. 2024
https://doi.org/10.1158/1078-0432.ccr-24-0841
- no dataset accession given
Cristiano Ferrario, John Mackey, Karen A Gelmon, Nathalie Levasseur, Poul H Sorensen, Htoo Z Oo, Gian L Negri, Veronica W L Tse, Sandra E Spencer, Grace Cheng, Gregg B Morin, Sonia Del Rincon, Tiziana Cotechini, Christophe Gonçalves, Charles C T Hindmarch, Wilson H Miller, Mehdi Amiri, Tayebeh Basiri, Victor Villareal-Corpuz, Sam Sperry, Kevin Gregorczyk, Gonzalo Spera, Nahum Sonenberg, Michael Pollak
Clin Cancer Res. 2024
https://doi.org/10.1158/1078-0432.ccr-24-0841
- no dataset accession given